Reply to thread

Ok I see....you’re new to pharma. This study already showed serious concerns with a small number of patients enrolled. Sorry bud. Yes the FDA doesn’t approve every drug that goes through the process. I thought that was pretty well known lol.


NUPLAZID is going to get the indication DRP just like it did for Parkinson’s.

I win again